Clinical Trials Browser

INDUSTRY × Expanded_access × Paclitaxel × Clear all

NCT03756311 2026-01-23

Expanded Access to NanoPac

No longer available

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT02307812 2025-01-09

Ramucirumab Use in Combination With Paclitaxel in Gastric or Gastroesophageal Junction Adenocarcinoma; Temporary Authorization for Use (ATU) in France

Approved for marketing

Gastrointestinal

Stomach Neoplasms